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Recent findings provide evidence that fungal structures can be detected in brain
tissue from Alzheimer’s disease (AD) patients using rabbit polyclonal antibodies raised
against whole fungal cells. In the present work, we have developed and tested specific
antibodies that recognize the fungal proteins, enolase and β-tubulin, and an antibody
that recognizes the fungal polysaccharide chitin. Consistent with our previous studies,
a number of rounded yeast-like and hyphal structures were detected using these
antibodies in brain sections from AD patients. Some of these structures were intracellular
and, strikingly, some were found to be located inside nuclei from neurons, whereas other
fungal structures were detected extracellularly. Corporya amylacea from AD patients also
contained enolase and β-tubulin as revealed by these selective antibodies, but were
devoid of fungal chitin. Importantly, brain sections from control subjects were usually
negative for staining with the three antibodies. However, a few fungal structures can be
observed in some control individuals. Collectively, these findings indicate the presence
of two fungal proteins, enolase and β-tubulin, and the polysaccharide chitin, in CNS
tissue from AD patients. These findings are consistent with our hypothesis that AD is
caused by disseminated fungal infection.
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INTRODUCTION
Despite intensive research effort, the precise etiology of Alzheimer’s disease (AD) remains
unknown. AD will affect over 60 million people worldwide by 2030 unless a remedy is found.
Substantial progress has been made in understanding the basic mechanisms of AD and the
prevailing hypothesis for AD pathogenesis is the amyloid cascade, in which secretion of amyloid
β peptide (Aβ) gives rise to the extracellular deposition of amyloid plaques that in turn induce
the aggregation of phosphorylated tau protein (O’Brien and Wong, 2011; Hampel et al., 2015).
Formation of intracellular tangles of phosphorylated tau leads to neuronal death and progressive
neurodegeneration (Revett et al., 2013). Although broadly accepted as a pathogenic mechanism in
AD, a number of studies have provided evidence for microbial infection as the main etiological
factor in AD (Harris and Harris, 2015; Olsen and Singhrao, 2015). Among them, viruses,
herpesviruses and particularly herpes simplex virus type 1 (HSV-1) have been the focus of
investigation (Itzhaki, 2014; Piacentini et al., 2014; Harris and Harris, 2015). Along this line, HSV-
1 DNA is found in AD patients (Wozniak et al., 2009), but whether this infection causes AD is
controversial since the vast majority of the human population bears this viral DNA in brain tissue
(Marques et al., 2001; Hemling et al., 2003; Wozniak et al., 2005). Another possibility considered by
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some is that bacteria such as Chlamydophila pneumoniae or
spirochetes are the etiological agents of AD (Balin et al., 2008;
Miklossy, 2011). This proposition is based on the finding that
C. pneumoniae structures and DNA are present in AD brain
tissue (Balin et al., 1998; Gerard et al., 2006); however, this
has been questioned by other researchers (Gieffers et al., 2000;
Ring and Lyons, 2000). The finding that Aβ peptide exhibits
antibacterial and anti-fungal activity point to the possibility that
amyloid plaque formation is a response to microbial infection
(Soscia et al., 2010). Indeed, Aβ peptide expression protects
against fungal and bacterial infections in expermental animal
models (Kumar et al., 2016). A model in which Aβ has a
protective-damaging action has been suggested.
The consideration that fungal infection is responsible for
the pathology observed in several neurodegenerative disorders,
including AD, has received scant attention. We previously
demonstrated that fungal proteins and DNA can be detected in
blood serum and cerebrospinal fluid (CSF) from AD patients
(Alonso et al., 2014a, 2015a). Additionally, proteomic analyses
revealed the presence of fungal proteins such as tubulin in
brain tissue, and fungal DNA was also detected by PCR
analyses (Alonso et al., 2014b). Through this analysis, several
fungal species were detected, suggesting that mixed disseminated
mycoses exists in the central nervous system (CNS) of AD
patients. Moreover, a number of fungal structures can be
directly visualized both inside and outside of neurons by
immunohistochemistry with rabbit polyclonal antibodies (Pisa
et al., 2015a,b). Thus, yeast-shaped cells and hyphae are evident
in brain tissue from patients, but not in control subjects.
The antibodies employed in these studies were raised against
whole fungal cells and, consequently, several different proteins
were visualized. These non-specific antibodies crossreact with
other fungal species, making them broad-spectrum. This lack
of specificity may represent a starting point to identify different
structures from a variety of fungal species. The use of specific
antibodies that recognize individual fungal components would be
a next step in evaluating possible fungal infection. Accordingly, in
the present study we have developed and tested three antibodies
to detect fungi in brain samples. One antibody has been raised
against the fungal polysaccharide chitin and two antibodies
have been developed against fungal proteins: one raised against
purified enolase from Candida famata and the other raised
against a β-tubulin peptide specific for fungi. Using these three
novel antibodies, we provide further support for presence of
fungal structures in brain tissue from AD patients, but not in
control subjects.
MATERIALS AND METHODS
Description of Control Subjects and
Patients
We analyzed samples from patients diagnosed with AD and
control individuals without neurological disease. The age and
gender of the subjects are listed in Supplementary Table S1.
All samples were supplied by a brain bank (Banco de Tejidos
CIEN, Madrid) and were analyzed anonymously. The transfer
of samples was carried out according to national regulations
concerning research on human biological samples. The Ethics
Committee of the Universidad Autónoma de Madrid approved
the study. In all cases, written informed consent was obtained.
Development of Anti-fungal Antibodies
Anti-chitin antibodies were generated as previously described
(Walker et al., 1990, 1991). Briefly, rabbits (female New Zea-
land) were immunized with reacetylated chitosan suspended in
phospate-buffered saline (PBS; 20 mM sodium phosphate buffer,
pH 7.4, 0.15 M NaCl). After weekly subcutaneous injection
(0.8 ml of PBS containing 0.1–0.6 mg reacetylated chitosan)
for 4 weeks, animals were ear bled using a vacuum cuff. The
antiserum was obtained and purified by affinity chromatography
on protein A-agarose. Bound antiserum was eluted with 0.2 M
glycine buffer, pH 2.9, neutralized, and dialyzed. To obtain
the fraction that bound di-N-acetylchitobiose, the antiserum
was further purified by affinity chromatography on ovalbumin-
agarose. The unbound material, which had no binding activity
toward ovalbumin (undetectable by western blotting), was stored
at−20◦C until needed. These antibodies were obtained at Mercer
University (USA) before IACUC was instituted. Nevertheless, we
followed all USDA-approved animal care regulations regarding
immunization and subsequent ear-bleeding at that time.
Antibodies against C. famata enolase were obtained
by injection of a purified fusion protein (maltose-binding
protein plus enolase). The enolase gene was obtained by PCR
amplification using the primers CGCCGCGGATCCATGGC
CGTCACTAAGTTATT and CGCCGCGTCGACTTATAA
TTGAGAAGCAGCGT. The amplifed fragment was cloned
into the pMAL vector (New England Biolabs, Ipswich, MA,
USA). After expression, the fusion protein was purified on
maltose columns and eluted with 0.5 ml PBS. Rabbits were
injected every 3 weeks with 1 mg of fusion protein suspended
in Freund’s adjuvant. A peptide corresponding to a region of
fungal β-tubulin (DVVRREAEGCDS) was purchased from
PolyPeptide Group (Strasbourg, France) and conjugated to
keyhole limpet hemocyanin (KLH). This peptide sequence is
conserved in several fungal species and is absent in human
β-tubulin. Rabbits and rats were inoculated with 0.60 mg of
β-tubulin peptide-KLH previously mixed with an equal volume
of Freund’s adjuvant every 2 weeks, up to three times in total.
The antibody titer and specificity of the antiserum were tested by
immunohistochemistry. The protocols employed were approved
by the ethics committee of Centro de Biologia Molecular “Severo
Ochoa” (identification number: ES280790000180). Animal
welfare and methods for sacrifice dictated by the European
Union have been followed. Animals were injected with sodium
pentothal as the anesthetic before bleeding.
Immunohistochemistry Analysis
CNS tissue was embedded in paraffin following standard
techniques and cut into 5 µm sections using a microtome
(Microm HM355s; Microm, Walldorf, Germany). For
immunohistochemical analysis, paraffin was removed and
sections were rehydrated and boiled for 2 min in 10 mM citrate
buffer and then incubated for 10 min with 50 mM ammonium
Frontiers in Microbiology | www.frontiersin.org 2 November 2016 | Volume 7 | Article 1772
fmicb-07-01772 November 4, 2016 Time: 16:13 # 3
Pisa et al. Fungal Components in Alzheimer’s Brain
chloride. Tissue sections were then incubated for 10 min with
PBS/Triton X-100 (0.1%) followed by 20 min with 2% bovine
serum albumin in PBS. Sections were incubated overnight
at 4◦C with mouse monoclonal antibodies against human
α-tubulin (Sigma), human phospho-PHF-tau, clone AT100
(Thermo Scientific), human neurofilament protein, clone 2F11
(Dako), or rabbit polyclonal antibodies raised against enolase,
β-tubulin, or chitin, all at 1:50 dilution. Thereafter, sections
were washed with PBS and further incubated for 1 h at 37◦C
with donkey anti-mouse IgG secondary antibody conjugated to
Alexa 555 (Invitrogen) at 1:500 dilution for α-tubulin, tau and
neurofilament, and donkey anti-rabbit IgG secondary antibody
conjugated to Alexa 488 (Invitrogen) at 1:500 dilution for anti-
fungal antibodies. To visualize nuclei, sections were stained with
4,6-diamino-2-phenylindole (DAPI; Merck) and treated with
autofluorescence eliminator reagent (Merck). The use of this
reagent is important to avoid autofluorescence since lipofuscin
is present in the aging brain. All images were collected and
analyzed on a Zeiss LSM710 confocal laser scanning microscope
equipped with the upright microscope stand AxioImager.M2
(Zeiss), running ZEN 2010 software. The spectral system
employed was Quasar + 2 PMTs. Images were deconvoluted
using Huygens software (4.2.2 p0; Scientific Volume Imaging)
and visualized and processed with Fiji/ImageJ software (NIH,
Bethesda, MD, USA). Stacks of 3D images were collected with the
high-speed, high-resolution A1R+ confocal microscope (Nikon)
combined with an inverted microscope, running NIS Elements
4.40 software.
Western Blotting Assay
Fungal proteins were precipitated with 10% trichloroacetic acid.
HeLa cells were grown in Dulbecco’s modified Eagle medium
supplemented with 10% fetal calf serum. These cells were
collected in sample buffer (0.37 M Tris–HCl, pH 6.8, 0.1 M DTT,
2% SDS, 17% glycerol, and 0.024% bromophenol blue) and boiled
for 5 min. Fungal and HeLa cell proteins were fractionated by
SDS-PAGE (15% polyacrylamide), transferred to nitrocellulose
membranes by wet immunotransfer and processed for western
blotting after blocking the membranes with 1% bovine serum
albumin. Incubation with specific rabbit antibodies for peptide
β-tubulin-KLH and enolase at a 1:200 dilution and specific
mouse antibody for human α-tubulin at a 1:500 dilution was
performed for 1 h. Donkey anti-rabbit and sheep anti-mouse
IgG horseradish peroxidase-conjugated antibodies (Amersham
Biosciences) and the ECL kit (Amersham) were used to detect
bound antibodies.
RESULTS
Characterization of Anti-fungal
Antibodies
Our previous findings strongly indicated the presence of fungal
structures in brain tissue from AD patients as revealed by
positive staining with antibodies raised against whole fungal
cells (Pisa et al., 2015a,b). Although the antibodies were
specific and did not recognize human antigens, the number of
proteins and other cellular components immunoreacting with
the polyclonal antibodies were unknown. We therefore generated
three antibodies against individual fungal components to further
evaluate the existence of these specific proteins/polysaccharides
in brain tissue. Anti-chitin antibodies have been successfully
tested against a number of fungal pathogens (Walker et al.,
1990, 1991) and selectively recognize chitin, which is not
present in human tissues. Additionally, we raised an antibody
against the glycolytic enzyme enolase cloned from C. famata,
and against a peptide specific for fungal β-tubulin. The
three rabbit polyclonal antibodies were first tested using
immunofluorescence microscopy on different Candida species.
Anti-chitin, immunoreacted strongly with C. parapsilosis and
C. tropicalis, while its reactivity with C. albicans, C. krusei, and
C. glabrata was weaker, suggesting that the chitin present in the
latter yeast species is differentially recognized by the antibody
perhaps due to differences in the structure or in the amount
of chitin present in the cell wall (Supplementary Figure S1A).
Additionally, the anti-enolase antibody immunoreacted strongly
with C. krusei and C. glabrata, whereas the anti-β-tubulin
antibody immunoreacted strongly with C. albicans, C. tropicalis,
and C. krusei. Rat polyclonal antibodies raised against the
β-tubulin peptide also immunoreacted with the different Candida
spp. (Supplementary Figure S1A). Thus, all three rabbit
antibodies and a rat antibody immunoreacted with Candida
spp. to different degrees. Western blotting analyses showed
that anti-enolase and anti-β-tubulin antibodies recognized
the corresponding protein bands in C. famata but not in
HeLa lysates (Supplementary Figure S1B). Conversely, a
commercial anti-human tubulin antibody detected tubulin in
HeLa lysates but not in C. famata. Further assessment of
the selectivity of the three fungal antibodies was performed
by testing their reactivity against human HeLa cells by
immunocytochemistry. As expected, none of the three antibodies
immunoreacted with components of HeLa cells (Supplementary
Figure S1C).
Detection of Chitin in Brain Tissue from
AD Patients
Chitin is a polysaccharide of N-acetylglucosamine that is an
integral part of the fungal cell wall. Chitin-like bodies have
been observed in AD brains stained with the flurochrome dye
calcofluor (Castellani et al., 2005). Moreover, levels of chitinase
(chitotriosidase), a human enzyme synthesized by macrophages,
are very high in serum and CSF from AD patients (Choi et al.,
2011; Watabe-Rudolph et al., 2012; Rosen et al., 2014; Melah et al.,
2015). We therefore tested for the first time specific anti-chitin
antibodies to survey potential fungal structures in AD brains.
Tissue sections from the entorhinal cortex of 10 AD patients
were double stained with an anti-chitin antibody (1:50 dilution,
shown in green) and a mouse monoclonal anti-human α-tubulin
antibody, which was used to identify microtuble structures
(shown in red). Cell nuclei were visualized by DAPI staining
(shown in blue; Figure 1). A number of structures were stained
with the anti-chitin antibody (Figure 1); some of which were in
the form of punctate bodies or yeast-like structures. On several
occasions, the stained structures were located inside the nucleus,
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while in other sections they were detected around the nucleus
or were extracellular. Hyphal structures could also be readily
detected with the anti-chitin antibody (Figure 1, AD10). In
summary, different structures that immunoreacted with the anti-
chitin antibody were detected in all 10 AD patients examined.
Since the morphology of these structures is similar to fungal cells
and hyphae, and they most probably contain chitin, it seems
plausible to suspect the existence of mycoses in the entorhinal
cortex of the patients.
Fungal Enolase and β-tubulin Are
Observed in AD Brain Tissue
To further assess the presence of specific fungal components
in AD brain tissue, we employed rabbit polyclonal anti-enolase
and fungal anti-β-tubulin antibodies. First, tissue sections of
the entorhinal cortex were double stained with an anti-enolase
(green) and a human anti-α-tubulin antibody (red; Figure 2,
Upper panels). Entorhinal sections were also double stained
with anti-β-tubulin (green) and a mouse monoclonal anti-
neurofilament antibody (red; Figure 2, Lower panels). In all
cases, nuclei were visualized by DAPI staining (blue). Fungal
enolase was clearly detected in brain tissue from AD patients. The
immunostained structures were similar to those described with
anti-chitin antibodies but the staining was more robust, perhaps
due to the better reactivity of the antibody against a protein
rather than a polysaccharide. Of particular interest was the
finding of intranuclear fungal structures (Figure 2, panel AD6).
Immunostaining with the anti-β-tubulin antibody highlighted
the presence of a number of punctate bodies in the cytoplasm
of a neuron (Figure 2, Lower panel AD2). The immunostained
punctate bodies are reminiscent of those observed after yeast
infection of cultured cells or mice (Pacheco et al., 2007; Pisa
et al., 2015a). In addition, several rounded fungal cells were
clearly visible in neuronal nuclei (Figure 2, Lower panels). As
controls for the different antibodies employed in this work,
immunohistochemistry analyses of AD sections were carried
out without primary antibodies. Certainly, in presence of anti-
enolase antibodies fungal structures are detected, whereas when
this primary antibody is omitted the green structures are not
observed (Supplementary Figure S2). Thus, when the secondary
antibody against rabbit polyclonal antibodies is employed, no
fungal structures are revealed. On the other hand, omission
of the secondary antibody that recognizes mouse monoclonal
antibodies does not visualize human α-tubulin.
To validate these results, we carried out double
immunostaining using rabbit polyclonal anti-chitin antibodies
and rat polyclonal fungal anti-β-tubulin antibodies. Curiously,
whereas some putative fungal structures were recognized by both
antibodies, other structures were immunostained with either
one or the other of these antibodies (Supplementary Figure S3).
Moreover, when the same structure was recognized by both
antibodies, the pattern of staining observed with each antibody
could differ (see Lower panels in Supplementary Figure S3).
To further determine whether some of the putative fungal
structures were intranuclear, we carried out orthogonal
projection analysis. Figure 3 shows that the anti-chitin antibody
immunoreacted with intranuclear material from patients AD7
and AD10 and an intranuclear fungal hypha is clearly visible
(Figure 3A). Remarkably, 3D analysis of one neuronal nucleus
demonstrated the presence of one yeast cell inside the nucleus.
Since intracellular infection by fungal cells requires that they be
alive, we conclude that infection of the neurons occured when the
patient was alive, and was not the consequence of post-mortem
contamination.
Different Regions of the AD Brain
Contain Fungal Chitin, Enolase, and
β-tubulin
Having shown that fungal bodies could be detected in the
entorhinal cortex of several patients, we next sought to
evaluate different CNS regions. To this end, sections from
the lateral frontal cortex (LFC), cerebellar cortex (CEC),
entorhinal cortex/hippocampus (ERH) and choroid plexus
(CP) of one AD patient were immunostained with the
three anti-fungal antibodies described above (Figure 4, shown
in green). For double immunostaining studies, we used
monoclonal anti-human phosphorylated tau with anti-chitin,
mouse monoclonal anti-human α-tubulin with anti-enolase, and
monoclonal neurofilament antibody with anti-β-tubulin (shown
in red). Results showed that a number of fungal structures
were detected in the four different regions, pointing to the idea
that fungal infection is disseminated in different brain regions
(Figure 4). It is possible that the fungal species and/or the
structures recognized by each antibody could be different. Once
again, the morphology of the structures immunostained with
the anti-fungal antibodies was similar to those described in the
entorhinal cortex. Accordingly, intranuclear yeast-shaped cells
were found in the LFC with anti-chitin antibodies. Also, hyphal
structures were detected in the LFC, CEC and ERH regions with
the anti-β-tubulin antibody. In CP, several yeast cells of about
1–2 µm are evidenced inside a blood vessel using the anti-
enolase antibody. Collectively, these results lead us to conclude
that specific fungal macromolecules such as chitin and proteins
are detected in fungal structures widespread in different brain
regions from the AD patient analyzed.
Fungal Components in Corpora
Amylacea
Corpora amylacea (CA) are small rounded bodies of
10–50 µm that are very abundant in the CNS of patients
with neurodegenerative diseases, including AD (Rohn, 2015;
Pisa et al., 2016). The composition of CA has been analyzed
in some detail. They mainly contain polyglucans and only
a small percentage (4%) corresponds to proteins (Robitaille
et al., 1980; Nishimura et al., 2000). The precise origin of CA
remains enigmatic, but it is thought that they accumulate in
elderly people and their formation occurs over long periods
(Sfanos et al., 2009). We recently found that fungal proteins
can be detected in CA with polyclonal antibodies raised
against whole fungal cells (Pisa et al., 2016). Thus, it was
of interest to examine whether specific fungal components
could be detected in CA using the new antibodies described
here. Thus, CA were localized from entorhinal cortex brain
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FIGURE 1 | Identification of fungal chitin in brain sections of AD patients by immunohistochemistry. Entorhinal cortex (ERH) sections (5 µm) from 10
different AD patients were immunostained for 1 h with rabbit polyclonal anti-chitin antibodies (green) and mouse monoclonal anti-human α-tubulin antibodies (red).
DAPI staining of nuclei appears in blue. Double immunostaining and confocal microscopy were carried out as indicated in the section “MATERIALS AND
METHODS.” Scale bar: 10 µm.
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FIGURE 2 | Detection of fungal enolase and β-tubulin in brain sections from AD patients using specific antibodies. Entorhinal cortex (ERH) sections
(5 µm) from nine different AD patients. Upper panels: samples were immunostained with rabbit polyclonal anti-enolase antibodies (green) and mouse monoclonal
anti-human α-tubulin antibodies (red). Lower panels: samples were immunostained with rabbit polyclonal fungal anti-tubulin antibodies (green) and mouse
monoclonal anti-human neurofilament antibodies (red). DAPI staining of nuclei appears in blue. Double immunostaining and confocal microscopy were carried out as
indicated in the section “MATERIALS AND METHODS.” Scale bar: 10 µm.
sections and were immunostained as described (Figures 1
and 2). Of note, fungal enolase could be clearly detected in the
vast majority of CA, which showed a high immunoreactivity
with the antibody (Figure 5, Upper panels). By contrast, CA
showed low reactivity with the anti-β-tubulin antibody, and
not all CA were immunolabeled (Figure 5, Middle panels).
Curiously, anti-chitin reactivity was not detected in any of the
CA, suggesting that chitin is not incorporated into these bodies
(Figure 5, Lower panels). Therefore, we conclude that some
specific fungal proteins can be detected in CA, and enolase is
a particularly good marker to use for detection. This may be
due to the fact that enolase is both a secreted and cytoplasmic
protein, whereas β-tubulin is cytoplasmic and forms part of the
fungal cytoskeleton. The finding that fungal chitin is not found
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FIGURE 3 | Orthogonal projections and 3D images. (A) Orthogonal projection of entorhinal cortex of patients AD7 and AD10. Images were acquired with a
LSM710 confocal microscope. (B) Different stacks of a 3D image of the entorhinal cortex of patient AD1. Images were acquired with a Nikon A1R+ confocal
microscope. Rabbit polyclonal anti-chitin antibody staining is shown in green and DAPI staining is shown in blue for all panels. Scale bars: 10 µm.
in CA may be due to the fact that CA are mainly composed of
polyglucans.
Analysis of Anti-fungal Antibody
Reactivity in Brain Tissue from Control
Subjects
Previous work from our group has found that control
subjects do not contain appreciable amounts of fungal proteins
in brain sections (Pisa et al., 2015a,b). Nevertheless, to
compare the burden of chitin, enolase and β-tubulin with AD
brain tissue, we performed immunohistochemistry on brain
sections from control individuals. We evaluated six control
subjects (described in Supplementary Table S1) and the more
representative results are shown in Figure 6. We failed to detect
chitin immunoreactivity in brain tissue from control subjects
(Figure 6I–L). Similar results were obtained using anti-enolase
and anti-β-tubulin (Figure 6A–H). Rare positivity could be
detected in control samples (Figure 6M–P). Nevertheless, this
low burden of fungal infection in control subjects may be of
interest to understand some symptoms such as the stimulation
of the immune system in elderly people (Cribbs et al., 2012;
Heneka et al., 2015). In conclusion, immunohistochemistry
analyses with three new antibodies comprehensively demonstrate
the presence of fungal components in brain tissue from AD
patients, but these fungal structures are very scanty in control
individuals.
DISCUSSION
Increasing evidence points to the possibility that the etiology
of AD is microbial infection (Harris and Harris, 2015). In this
regard, we have provided compelling evidence that supports
the notion that mixed fungal infections occur in AD. Indeed,
several fungal components can be found in brain tissue from AD
patients (Alonso et al., 2014a,b, 2015b; Pisa et al., 2015a,b), and
fungal proteins and polysaccharides in blood serum, consistent
with the concept of disseminated fungal infection (Alonso et al.,
2014a). Fungal DNA and proteins are also detected in CSF from
AD patients (Alonso et al., 2015b), and proteomic analysis of
brain tissue from AD patients unequivocally reveals the presence
of fungal proteins and DNA from a variety of fungal species
(Alonso et al., 2014b; Pisa et al., 2015b). Collectively, these studies
show that AD patients have mixed fungal infections that can
be detected directly in brain sections and also in blood serum
and CSF.
Our present findings indicate that fungal components such
as chitin, enolase and β-tubulin, can be detected with specific
antibodies. Several former observations can be reconciled with
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FIGURE 4 | Detection of fungal enolase, β-tubulin, and chitin in
different CNS regions of patient AD11. Immunohistochemistry analysis of
(Continued)
FIGURE 4 | Continued
CNS sections from patient AD11 were performed by confocal microscopy
as detailed in the section of “MATERIALS AND METHODS.” LFC, lateral
frontal cortex; CEC, cerebellar cortex; ERH, entorhinal cortex/hippocampus;
CP, choroid plexus. Anti-enolase, anti-tubulin, and anti-chitin antibodies are
shown in green. Double staining with mouse monoclonal anti-human α-tubulin
inmunostaining for the anti-enolase antibody sample, human anti-neurofilament
immunostaining for fungal anti-tubulin antibody sample, and anti-TauT100
staining for human anti-chitin antibody sample are shown in red. DAPI staining
appears in blue. The different CNS sections are indicated in the panels. Scale
bar: 10 µm.
our present results. Thus, the existence of chitin-like material
in AD brains stained with calcofluor (Castellani et al., 2005,
2007) can be easily explained if we consider that our present
observations provide strong evidence for fungal chitin in AD
brains, which is in accord with the finding of elevated inducible
chitinase in serum and CSF from some neurodegenerative
diseases, including AD (Choi et al., 2011; Rosen et al., 2014). This
is consistent with the existence of disseminated fungal infections
since the presence of the substrate (chitin) would induce synthesis
of the enzyme (Theis and Stahl, 2004). In fact, elevated levels of
chitinase may constitute a good biomarker for early diagnosis and
to monitor the evolution of AD (Watabe-Rudolph et al., 2012;
Wildsmith et al., 2014).
The amyloid-cascade hypothesis posits that the unregulated
synthesis of Aβ and the concomitant formation of extracellular
amyloid plaques leads to intracellular neuron injury that is
mediated by the formation of tangles of phosphorylated tau
protein (O’Brien and Wong, 2011; Revett et al., 2013; Hampel
et al., 2015). The identification of Aβ as a potent anti-bacterial
and anti-fungal peptide (Soscia et al., 2010), bolsters the claim
that microbial infection of AD patients may be responsible
for the induction of Aβ synthesis. Indeed, a recent study in
experimental animals showed that Aβ is involved in combating
bacterial and fungal infections (Kumar et al., 2016). In this sense,
Aβ can be envisaged as part of the innate immune response to
microbial infections. Kumar et al. (2016) have suggested that
a putative infection could trigger the synthesis of Aβ leading
to amyloid deposition and neuronal death. In this regard, the
main cause of neuronal damage could still be ascribed to amyloid
plaques and the inhibition of their formation may alleviate
clinical symptoms. Another view, and one that we favor, is that
the existence of a fungal infection per se is responsible for cell
damage and for the majority of clinical symptoms observed
in AD (Alonso et al., 2014b; Pisa et al., 2015b). Many fungal
species can synthesize toxins that could be detrimental for cellular
metabolism (Kamei and Watanabe, 2005; Russo et al., 2016).
For example, very recently a new fungal toxin, candidalysin,
has been identified in C. albicans (Moyes et al., 2016), which
targets cellular membranes, leading to increased membrane
permeability and lysis. Even for fungal species that do not
synthesize mycotoxins, the continuous secretion of lytic enzymes
could contribute to their virulence and pathogenesis for cells.
Indeed, a number of lytic enzymes that digest proteins and lipids
are secreted by fungi (Braga-Silva and Santos, 2011). This would
be particularly detrimental for neurons containing intracellular
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FIGURE 5 | Presence of fungal enolase and β-tubulin in corpora amylacea. Entorhinal cortex (ERH) sections from 10 AD patients were incubated with rabbit
polyclonal antibodies against fungal enolase, β-tubulin, and chitin as described in the section of “MATERIALS AND METHODS” (green), and mouse monoclonal
antibodies against human α-tubulin and neurofilaments used as described in Figures 1 and 2, respectively, is shown in red. DAPI appears in blue. Scale bar: 20 µm.
fungi, as described here and in other studies (Pisa et al., 2015a,b).
It must also be considered that the continuous secretion of
polyglucans will have deleterious effects on cell metabolism and
on the immune system (Drummond and Brown, 2011; Saijo and
Iwakura, 2011; van der Meer et al., 2015). Therefore, it would be
possible that the inhibition and eradication of fungal infection
from brain tissue would be sufficient not only to ameliorate, but
perhaps to partially revert AD clinical symptoms.
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FIGURE 6 | Immunohistochemistry analysis of fungal enolase, β-tubulin, and chitin in brain sections from control subjects. CNS sections from six
control subjects (C1–C6) were analyzed by confocal microscopy as detailed in the section of “MATERIALS AND METHODS.” Sections were immunostained with
rabbit polyclonal antibodies against enolase, β-tubulin, and chitin (green) and human α-tubulin and neurofilaments (red), as described in Figures 1 and 2. (A–D,M):
anti-enolase and anti-human α-tubulin antibodies. (E–H,N): fungal anti-β-tubulin and human anti-neurofilaments antibodies. (I–L,O–P): anti-chitin and anti-human
α-tubulin antibodies. (A,I,O): C1. (B,E): C2. (C,F): C3. (D,N): C4. (G–H,J,M): C5. (K–L,P): C6. (A,G,I,J,O): LFC. (B,E,H,M,N): CEC. (C,D,F,K,P): ERH. (L): CP.
DAPI staining appears in blue. The different panels are indicated in the figure. Scale bar: 20 µm for panels (A–L) and 10 µm for panels (M–P).
To test if AD symptoms are reversible, clinical trials are
needed to evaluate different anti-fungal agents for the evolution
of AD symptoms. Indeed, at least two patients diagnosed with
AD and treated with anti-fungal compounds exhibited a good
recovery from dementia (Ala et al., 2004; Hoffmann et al., 2009).
In these two cases, amyloid deposition was not targeted, but a
good recovery was still observed. However, it was concluded that
these patients were possibly misdiagnosed and in fact could have
had cryptococcal meningitis. Nevertheless, if AD is provoked
by fungal infections, the test for fungal meningitis would be
positive in most cases. Therefore, if dementia provoked by a
fungal infection can be reversed by anti-fungal treatment (Ala
et al., 2004; Hoffmann et al., 2009), a similar situation could be
envisaged if AD dementia is the consequence of mycoses.
Aβ, as well as other small peptides, such as defensins, form part
of the innate immune response and are elevated in AD patients
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(Williams et al., 2013; Watt et al., 2015; Mattar et al., 2016).
The use of transgenic mice that express Aβ or defensins have
provided evidence that these small peptides play an important
role in the innate immune response against microbial infections
(Salzman et al., 2003; Chu et al., 2012; Kumar et al., 2016).
Defensin-1 is apparent in astrocytes of the AD hippocampus and
choroidal plexus (Williams et al., 2013). Moreover, elevated levels
of α-defensins-1 and 2 are found in serum from peripheral blood
of AD patients (Watt et al., 2015). These observations indicate an
inflammatory reaction in these patients, which is consistent with
our suggestion of mixed disseminated mycosis.
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FIGURE S1 | Characterization of the antibodies employed in this work. (A)
The commercial kit Euroimmun was used for immunofluorescence analysis of
rabbit polyclonal antibodies against enolase protein at 1:10 dilution, and β-tubulin,
and chitin proteins at 1:50 dilution. The donkey anti-rabbit IgG secondary antibody
conjugated to Alexa 488 (Invitrogen) was used at 1:500 dilution. Scale bar: 5 µm.
(B) Western blotting of C. famata and HeLa cells proteins with fungal peptide
anti-β-tubulin-KLH at 1:200 dilution, fungal enolase at 1:200 dilution and human
α-tubulin at 1:500 dilution, as primary antibodies; donkey anti-rabbit IgG
horseradish peroxidase at 1:5000 dilution as secondary antibody for β-tubulin,
enolase and control; sheep anti-mouse IgG horseradish peroxidase antibody at
1:1000 dilution as secondary antibody for α-tubulin. Control: without primary
antibody. (C) Immunofluorescence of HeLa cells cultured and incubated with
chitin, enolase and β-tubulin antibodies at 1:50 dilution (green), and human
α-tubulin at 1:50 dilution (red). DAPI staining appears in blue. Scale bar: 20 µm.
FIGURE S2 | Sections (5 µm) of the entorhinal cortex of patient AD5 were
double immunostained with anti-enolase (green) and anti-α-tubulin (red)
antibodies (Left panel). A control without anti-rabbit polyclonal antibodies was
carried out (Middle panel) or without secondary antibodies against mouse
monoclonal antibodies (Right panel). DAPI staining is in blue. Scale bar: 30 µm.
FIGURE S3 | Immunohistochemistry of AD brain sections. Sections (5 µm)
of the entorhinal cortex of patients AD1 and AD2 were double immunostained with
anti-chitin (green) and anti-β-tubulin (red) antibodies. Scale bar: 10 µm.
TABLE S1 | Age and gender of subjects analyzed in this study.
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